Startseite>>Signaling Pathways>> Chromatin/Epigenetics>> Histone Methyltransferase>>EPZ020411 hydrochloride

EPZ020411 hydrochloride

Katalog-Nr.GC36000

EPZ020411 Hydrochlorid ist ein selektiver Inhibitor von PRMT6 mit einem IC50 von 10 nM, es hat eine >10-fache SelektivitÄt fÜr PRMT6 gegenÜber PRMT1 und PRMT8. EPZ020411 Hydrochlorid kann fÜr die Krebsforschung verwendet werden.

Products are for research use only. Not for human use. We do not sell to patients.

EPZ020411 hydrochloride Chemische Struktur

Cas No.: 2070015-25-5

Größe Preis Lagerbestand Menge
10mM (in 1mL Water)
198,00 $
Auf Lager
5mg
180,00 $
Auf Lager
10mg
315,00 $
Auf Lager
50mg
585,00 $
Auf Lager
100mg
1.035,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

EPZ020411 hydrochloride is a potent and selective inhibitor of PRMT6 with IC50 of 10 nM, has >10 fold selectivity for PRMT6 over PRMT1 and PRMT8.IC50 value: 10 nMTarget: PRMT6in vitro: EPZ020411 inhibits methylation of PRMT6 substrates in cells. EPZ020411 does-dependently inhibits H3R2 methylation in PRMT6-overexpressing cells.in vivo: EPZ020411 shows good bioavailability following subcutaneous (SC) dosing in rats making it a suitable tool for in vivo studies.

[1]. Mitchell LH, et al. Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 ToolCompound. ACS Med Chem Lett. 2015 Apr 6;6(6):655-659.

Bewertungen

Review for EPZ020411 hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 2 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for EPZ020411 hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.